within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01C_BetaLactamAntibacterialsPenicillins.J01CF04_Oxacillin;

model Oxacillin
  extends Pharmacolibrary.Drugs.ATC.J.J01CF04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J01CF04</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Oxacillin is a narrow-spectrum beta-lactam antibiotic of the penicillin class, primarily used for the treatment of infections caused by penicillinase-producing staphylococci. It is still clinically approved and used especially for serious Staphylococcus aureus infections sensitive to methicillin-class drugs.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after intravenous administration.</p><h4>References</h4><ol><li><p>Bock, M, et al., &amp; Moser, C (2023). Attainment of Target Antibiotic Levels by Oral Treatment of Left-Sided Infective Endocarditis: A POET Substudy. <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> 77(2) 242–251. DOI:<a href=\"https://doi.org/10.1093/cid/ciad168\">10.1093/cid/ciad168</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36947131/\">https://pubmed.ncbi.nlm.nih.gov/36947131</a></p></li><li><p>Visser, LG, et al., &amp; van den Broek, PJ (1993). Clinical pharmacokinetics of continuous intravenous administration of penicillins. <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> 17(3) 491–495. DOI:<a href=\"https://doi.org/10.1093/clinids/17.3.491\">10.1093/clinids/17.3.491</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8218695/\">https://pubmed.ncbi.nlm.nih.gov/8218695</a></p></li><li><p>Adrianzén Vargas, MR, et al., &amp; Barron, DJ (2004). Pharmacokinetics of intravenous flucloxacillin and amoxicillin in neonatal and infant cardiopulmonary bypass surgery. <i>European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery</i> 25(2) 256–260. DOI:<a href=\"https://doi.org/10.1016/j.ejcts.2003.11.017\">10.1016/j.ejcts.2003.11.017</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/14747123/\">https://pubmed.ncbi.nlm.nih.gov/14747123</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Oxacillin;
